University of Minnesota
Saint Paul, Minnesota, 55108, United States
NCT Number: NCT01187875
Dietary fiber consumption may contribute to weight regulation by improving satiety. In an earlier study the investigators found that a muffin containing resistant starch was more effective than other fibers in altering satiety. The objective of this study is to determine if 2 resistant starches consumed in muffins alter satiety and whether a mixture of resistant starches is more effective than either alone in enhancing satiety.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Early Phase 1
Saint Paul, Minnesota, 55108, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dextrin control administered in a muffin treatment.
9g Hi-maize resistant starch administered in a muffin treatment.
9g Novalose 330 resistant starch administered in a muffin treatment.
4.5g Hi-maize and 4.5g Novalose 330 in a muffin treatment.
Time frame: 0 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 15 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 30 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 45 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 60 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 90 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 120 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 180 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 240 minutes postprandially
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
Time frame: 240 minutes postprandially and over 24 hours
Time frame: 0, 240 minutes
Time frame: 24 hours
Subjective ratings of bloating, stool consistency, and flatulence on VAS. A stool count was also recorded.
University of Minnesota
Other
Satiety Response of Resistant Starches
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695441
Healthy Adults, Postprandial Glycemic Response
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT07454551
Healthy Adults, Young
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05379101
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Rochester, Minnesota, United States
View Trial DetailsNCT07636018
Healthy Adults
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial Details